| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $377K | -24.6% |
| Cost of Revenue | $3.6M | +517.8% |
| R&D Expense | $25.5M | +28.7% |
| SG&A Expense | $41.0M | +60.5% |
| Operating Income | -$90.9M | -67.2% |
| Interest Expense | $1.3M | — |
| Pre-tax Income | -$103.2M | -83.9% |
| Net Income | -$89.0M | -76.7% |
| EPS (Basic) | -$1.00 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.7M | -48.6% |
| Accounts Receivable | $17K | -91.5% |
| Current Assets | $43.9M | -46.8% |
| Total Assets | $54.0M | -37.9% |
| Current Liabilities | $41.2M | +445.1% |
| Total Liabilities | $43.0M | +469.5% |
| Stockholders' Equity | -$9.7M | -115.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$71.0M | -74.9% |
| Capital Expenditures | $1.5M | +4.8% |
| Investing Cash Flow | -$4.7M | -27.6% |
| Financing Cash Flow | $38.2M | -63.4% |
| Free Cash Flow | -$72.5M | -72.4% |
| -53.8% |